Antidote Technologies

What it does

Antidote is an AI-native clinical trial patient recruitment platform that matches patients with relevant clinical trials using AI-powered eligibility screening. Patients describe their condition and medical history through a structured questionnaire; Antidote's AI matches their profile against hundreds of active trial eligibility criteria and surfaces trials they may qualify for - connecting them directly to site coordinators. For pharmaceutical sponsors and CROs, Antidote provides a recruitment channel that accesses a large pool of patient-consented profiles for targeted trial recruitment outreach. AI capabilities include natural language eligibility criteria parsing that converts complex inclusion/exclusion criteria into structured matching logic, real-time patient-to-trial matching, and predictive enrollment modeling that forecasts recruitment timelines based on site and patient pool analysis.

Strengths

• Pharmaceutical companies, biotech firms, and CROs use Antidote to accelerate clinical trial enrollment - AI patient matching reducing the time to find eligible participants and improving enrollment rates at sites with historically slow recruitment.
• Antidote is an AI-native clinical trial patient recruitment platform that matches patients with relevant clinical trials using AI-powered eligibility screening.
• Patients describe their condition and medical history through a structured questionnaire; Antidote's AI matches their profile against hundreds of active trial eligibility criteria and surfaces trials they may qualify for - connecting them directly to site coordinators.

Watch-outs

• Patient pool quality depends on self-reported data: Antidote's matching relies on patient-reported health information — accuracy of matches depends on how completely and accurately patients describe their condition, which varies and may not reflect clinical record data.
• One channel among many in recruitment: Antidote is a patient recruitment channel, not a complete recruitment solution — sponsors typically use multiple recruitment strategies (site referrals, registries, social media) alongside Antidote for full enrollment programs.
• Trial complexity affects matching accuracy: Simple eligibility criteria match well through AI; complex protocols with detailed laboratory value requirements and multi-stage screening procedures are harder to fully automate in patient-facing screening tools.

Pricing

Antidote enterprise contracts not published. Priced per trial and recruitment program scope. Pharmaceutical and CRO contracts negotiated annually.